Matches in Nanopublications for { ?s ?p "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1266820.RAfIGX2kSfeZN_ZlAh86QnRlwwVHQJ5QvmP575aDinK5s130_assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266820.RAfIGX2kSfeZN_ZlAh86QnRlwwVHQJ5QvmP575aDinK5s130_provenance.
- NP1266824.RAcPwgW5M5HlFeCyN9nU6wjCoJwRFcFcrGgoaTkboDTRQ130_assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266824.RAcPwgW5M5HlFeCyN9nU6wjCoJwRFcFcrGgoaTkboDTRQ130_provenance.
- NP1266822.RAlgOWpjaopXwzIMxbxgMf1iFFPOFpU5gDG1hO-cVOgZY130_assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266822.RAlgOWpjaopXwzIMxbxgMf1iFFPOFpU5gDG1hO-cVOgZY130_provenance.
- NP1266819.RAwEo9T5ErEudqLhs3IDNDpkd-fiP6Fu0jt5zJFxahTAY130_assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266819.RAwEo9T5ErEudqLhs3IDNDpkd-fiP6Fu0jt5zJFxahTAY130_provenance.
- NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266821.RA6haDS2OsQnhgkBB6TE8NuzzNw3xtUzDI6VdX2lRjo_E130_provenance.
- NP1266823.RA9Fjrp-3eorcX4HJ1Xw69Gza6iZaqptgYDTDc3p4zBUY130_assertion description "[This research highlights new bioactivities for gracilins, such as BACE1 and ERK inhibition, and provides more evidence for their potential therapeutic application in neurodegenerative diseases due to their multi-target activities, especially in AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266823.RA9Fjrp-3eorcX4HJ1Xw69Gza6iZaqptgYDTDc3p4zBUY130_provenance.